Human papillomavirus genotypes in Pacific Islander cervical cancer patients
Conclusion Pacific Islanders referred to TAMC present with a disproportionally higher rate of regional and advanced disease. Significantly, only 28% of invasive cervical cancers in the Pacific Island population sampled could have been potentially be prevented using the available quadrivalent vaccine targeting HPV 16/18; however, 88% could be covered by the recently licensed nonavalent vaccine.
Source: Gynecologic Oncology Reports - Category: OBGYN Source Type: research
More News: Adenocarcinoma | Cancer | Cancer & Oncology | Cancer Vaccines | Carcinoma | Cervical Cancer | Cervical Cancer Vaccine | Genital Warts | Health Management | Human Papillomavirus (HPV) | Nutrition | OBGYN | Pathology | Squamous Cell Carcinoma | Study | Vaccines